OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 15.19M | 14.61M | 14.69M | 15.40M | 13.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.14M | 61.57M | 62.95M | 66.68M | 62.69M |
| Operating Income | -62.14M | -61.57M | -62.95M | -66.68M | -62.69M |
| Income Before Tax | -58.71M | -58.75M | -59.52M | -63.46M | -60.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.71 | -58.75 | -59.52 | -63.46 | -60.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.71M | -58.75M | -59.52M | -63.46M | -60.31M |
| EBIT | -62.14M | -61.57M | -62.95M | -66.68M | -62.69M |
| EBITDA | -61.74M | -61.13M | -62.50M | -66.22M | -62.22M |
| EPS Basic | -3.50 | -4.33 | -4.40 | -4.78 | -40.24 |
| Normalized Basic EPS | -2.18 | -2.70 | -2.75 | -2.94 | -25.11 |
| EPS Diluted | -3.50 | -4.33 | -4.40 | -4.78 | -40.24 |
| Normalized Diluted EPS | -2.18 | -2.70 | -2.75 | -2.94 | -25.11 |
| Average Basic Shares Outstanding | 90.67M | 54.31M | 54.06M | 53.24M | 40.02M |
| Average Diluted Shares Outstanding | 90.67M | 54.31M | 54.06M | 53.24M | 40.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |